2019
DOI: 10.1039/c9fo00018f
|View full text |Cite
|
Sign up to set email alerts
|

Reply to the Comment on “Revisiting the carrageenan controversy: do we really understand the digestive fate and safety of carrageenan in our foods?” by M. Weiner and J. McKim, Food Funct., 2019, 10: DOI: 10.1039/C8FO01282B

Abstract: Diversity of food-grade carrageenan and rising levels of exposure to carrageenan mandate re-evaluation of its safety for the entire population.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
14
0

Year Published

2019
2019
2021
2021

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 6 publications
(15 citation statements)
references
References 24 publications
1
14
0
Order By: Relevance
“…Interestingly, Table 4 summarizes neo-formed bioactive peptides that were only recovered from digesta containing stabilizers. This supports the notion that stabilizer-protein interactions may affect In light of an expected high dietary exposure of children to stabilizers, like CGN [36], proteomic analyses focused on aspirates collected from a child IVD model. First, peptide sequences in CMD digesta samples were identified and compared with known milk-derived bioactive peptides.…”
Section: Monitoring Stabilizer Effects On In Vitro Digestive Proteolysupporting
confidence: 67%
See 3 more Smart Citations
“…Interestingly, Table 4 summarizes neo-formed bioactive peptides that were only recovered from digesta containing stabilizers. This supports the notion that stabilizer-protein interactions may affect In light of an expected high dietary exposure of children to stabilizers, like CGN [36], proteomic analyses focused on aspirates collected from a child IVD model. First, peptide sequences in CMD digesta samples were identified and compared with known milk-derived bioactive peptides.…”
Section: Monitoring Stabilizer Effects On In Vitro Digestive Proteolysupporting
confidence: 67%
“…In light of an expected high dietary exposure of children to stabilizers, like CGN [ 36 ], proteomic analyses focused on aspirates collected from a child IVD model. First, peptide sequences in CMD digesta samples were identified and compared with known milk-derived bioactive peptides.…”
Section: Resultsmentioning
confidence: 99%
See 2 more Smart Citations
“…Carrageenan is not degraded nor absorbed in the gastrointestinal tract [110,111,112] and should not contain low Mw fractions, poligeenan or degraded carrageenan, since it exhibits toxicological properties at high doses [110] and can induce gastrointestinal irritation and cancer in animal models [112] or can lead to cell death and inflammatory responses on human colonic epithelial cells [113,114], bacterial dysbiosis and shifted community composition [115] and decreased anti-inflammatory bacteria [116]. Further studies of its impact on digestive proteolysis, the colon microbiome and inflammation [117,118,119] and the effects on predisposed populations [119,120] are required. Carrageenans are also used for the pharmaceutical sector [106,107], based on anti-inflammatory [121], antiviral [6,122,123,124,125,126], anticoagulant [17,127], immunomodulatory [128], antitumoral [129], antioxidant [17,129,130], anti-angiogenic [97] and neuroprotective [129] activities.…”
Section: Components: Properties and Extractionmentioning
confidence: 99%